Riskpilot← Back to searchSign inGet full accessSPEKAEL AB
ABActiveOrg 5590906136Vendergatan 9Activities of holding companies · NACE 6421Est. 20160 employees
Revenue 2024
SEK 5K
-92% vs 2023
EBITDA margin
-2411.4%
-39% vs 2023
Equity ratio
99.1%
Financial strength
Net profit 2024
SEK 1,9M
+330% vs 2023
| Revenue | SEK 5K | -92% |
| EBITDA | SEK -126K | -39% |
| Net profit | SEK 1,9M | +330% |
| Total assets | SEK 12M | -4% |
| Equity | SEK 11,9M | -4% |
| Employees | 0 | — |
Legal name
SPEKAEL AB
Org number
5590906136
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
13 december 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva vårdverksamhet, konsulttjänster inom vård och ledarskap, fastighetsförvaltning och därmed förenlig verksamhet.
Address
Vendergatan 9
Email
spetzmikael@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 32 | 67 | 5 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −65 | −63 | −67 | −91 | −126 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −65 | −63 | −67 | −91 | −126 |
| Net financials | 2 814 | 2 790 | 1 864 | 555 | 2 065 |
| Profit before tax | 2 748 | 2 765 | 1 798 | 464 | 1 939 |
| Tax | −30 | −32 | — | −13 | — |
| Net profit | 2 718 | 2 733 | 1 798 | 451 | 1 939 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 141 | 18 643 | 13 139 | 12 557 | 12 047 |
| Equity | 16 818 | 15 550 | 13 048 | 12 499 | 11 938 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 285 | 3 093 | 91 | 58 | 110 |
| Total debt | 285 | 3 093 | 91 | 58 | 110 |
EBITDA margin
-2411.4%
This company
15.8%
Market median
-15362% vs market
20202024
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
20202024
Return on equity
16.2%
This company
18.4%
Market median
+12% vs market
20202024
Net profit margin
37008.3%
This company
8.1%
Market median
+456793% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EG Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
AM Chief Auditor | Chief Auditor | 2025 – 2025 |
BH Audit | Audit | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPEKAEL AB (this company)
Läkarhusen i Väst Holding ABBoard members of SPEKAEL AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Mikaela Hedin Göran | Chief Auditor | 0 companies |
| Bo Helge Eugén Östh | Audit | 0 companies |
| Erik Gunnar Hansson | Chief Auditor | 0 companies |
| Rolf Mikael Spetz | Board of Directors | 0 companies |
| Marianne Sofia Spetz | Deputy Board Member | 0 companies |